Table 1 Demographic and clinical characteristics of the main study group (working-age individuals, 18–64 years). The number of individuals refer to a weighted number in each group
BMI (kg/m2) | Overall | NW (18.5–24.9 kg/m2) | OW (25.0–29.9 kg/m2) | OBI (30.0–34.9 kg/m2) | OBII – III (35.0 + kg/m2) | p |
|---|---|---|---|---|---|---|
n (%) | 4,134 (100) | 1,630 (39.4) | 1,481 (35.8) | 688 (16.6) | 335 (8.1) | |
Age (years), mean (SD) | 42.2 (13.5) | 38.4 (13.4) | 45.0 (12.3) | 45.0 (13.3) | 42.8 (14.8) | < 0.001 |
Sex, n (%) | ||||||
Female | 2,027 (49.0) | 923 (56.7) | 608 (41.0) | 300 (43.7) | 196 (58.4) | < 0.001 |
Male | 2,107 (51.0) | 706 (43.3) | 873 (59.0) | 388 (56.3) | 139 (41.6) | |
BMI (kg/m2), mean (SD) | 27.2 (5.2) | 22.6 (1.6) | 27.3 (1.4) | 32.0 (1.3) | 39.1 (4.0) | < 0.001 |
Follow-up, years (SD) | 4.7 (0.9) | 4.8 (0.7) | 4.7 (1.0) | 4.7 (1.0) | 4.7 (0.9) | < 0.001 |
MetCs, mean (SD) | 1.18 (1.0) | 0.73 (0.8) | 1.24 (1.0) | 1.73 (1.1) | 1.93 (1.18) | < 0.001 |
MetCs category, n (%) | ||||||
0 | 1,278 (30.9) | 742 (45.5) | 395 (26.7) | 93 (13.6) | 47 (14.0) | < 0.001 |
1 | 1,438 (34.8) | 625 (38.4) | 538 (36.3) | 199 (28.9) | 76 (22.6) | |
> 1 | 1,419 (34.3) | 263 (16.1) | 548 (37.0) | 396 (57.6) | 213 (63.5) | |
Comorbidities, n (%) | ||||||
Psychiatric disease | 952 (23.0) | 349 (21.4) | 311 (21.0) | 210 (30.6) | 82 (24.5) | 0.004 |
Musculoskeletal disorder | 1,981 (47.9) | 684 (42.0) | 726 (49.0) | 380 (55.3) | 191 (57.0) | < 0.001 |
Metabolic disorder | 466 (11.3) | 76 (4.7) | 172 (11.6) | 133 (19.3) | 84 (25.1) | < 0.001 |
Any CVD | 980 (23.7) | 237 (14.6) | 384 (25.9) | 234 (34.0) | 125 (37.3) | < 0.001 |
Asthma | 275 (6.6) | 98 (6.0) | 84 (5.7) | 47 (6.8) | 46 (13.6) | 0.009 |
Cancer | 179 (4.3) | 55 (3.4) | 65 (4.4) | 45 (6.5) | 14 (4.1) | 0.01 |
Sleep apnea | 262 (6.3) | 35 (2.1) | 92 (6.2) | 79 (11.5) | 56 (16.8) | < 0.001 |
T2DM | 191 (4.6) | 8 (0.5) | 55 (3.7) | 71 (10.3) | 57 (17.0) | < 0.001 |